• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例新冠病毒长期感染的非典型病例。

An Atypical Case of Prolonged COVID-19 Infection.

作者信息

Lewis Connor, Gupta Akash, Gupta Neil K

机构信息

Internal Medicine, Yale School of Medicine, New Haven, USA.

Internal Medicine, Yale New Haven Hospital, New Haven, USA.

出版信息

Cureus. 2022 Jul 16;14(7):e26921. doi: 10.7759/cureus.26921. eCollection 2022 Jul.

DOI:10.7759/cureus.26921
PMID:35983394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9377411/
Abstract

Immunocompromised patients with COVID-19 can have prolonged disease courses that require escalation in care to inpatient or ICU settings. We report a case of a prolonged, active COVID-19 infection in an immunocompromised 61-year-old female with a history of non-Hodgkin's lymphoma. During her hospitalization, her cycle thresholds (CT) continued to worsen despite clinical improvement. We compared our patient's course and CTs to other reported cases in immunocompromised patients, investigating the efficacy of CTs and their use in evaluating disease progression and severity. RT-PCR tests targeting specific types of replicative viral RNA may have more utility in assessing disease severity and infectivity in immunocompromised patients. Our patient's disease course, similar to other reported cases, illustrates the need for improved treatment protocols and infection prevention for the immunocompromised population against SARS-CoV-2.

摘要

患有新冠肺炎的免疫功能低下患者可能会有病程延长的情况,这需要将护理级别提升至住院或重症监护病房。我们报告了一例61岁免疫功能低下女性的新冠肺炎长期活跃感染病例,该女性有非霍奇金淋巴瘤病史。在她住院期间,尽管临床症状有所改善,但她的循环阈值(CT)持续恶化。我们将我们患者的病程和CT值与其他免疫功能低下患者的报告病例进行了比较,研究了CT值在评估疾病进展和严重程度方面的有效性及其应用。针对特定类型复制性病毒RNA的逆转录聚合酶链反应(RT-PCR)检测在评估免疫功能低下患者的疾病严重程度和传染性方面可能更有用。我们患者的病程与其他报告病例相似,说明了针对免疫功能低下人群对抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)需要改进治疗方案和感染预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/e2e00d2de8e4/cureus-0014-00000026921-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/39e7e07a53a7/cureus-0014-00000026921-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/73982f39b32d/cureus-0014-00000026921-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/e2e00d2de8e4/cureus-0014-00000026921-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/39e7e07a53a7/cureus-0014-00000026921-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/73982f39b32d/cureus-0014-00000026921-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c2/9377411/e2e00d2de8e4/cureus-0014-00000026921-i03.jpg

相似文献

1
An Atypical Case of Prolonged COVID-19 Infection.一例新冠病毒长期感染的非典型病例。
Cureus. 2022 Jul 16;14(7):e26921. doi: 10.7759/cureus.26921. eCollection 2022 Jul.
2
Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.两名免疫功能低下患者的 SARS-CoV-2 病毒持续排出:病例报告
BMC Infect Dis. 2021 Aug 3;21(1):743. doi: 10.1186/s12879-021-06429-5.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
COVID-19 in Elderly, Immunocompromised or Diabetic Patients-From Immune Monitoring to Clinical Management in the Hospital.COVID-19 与老年、免疫功能低下或糖尿病患者——从免疫监测到医院内的临床管理。
Viruses. 2022 Apr 1;14(4):746. doi: 10.3390/v14040746.
5
Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma: a case report.一名晚期HIV感染者合并弥漫性大B细胞淋巴瘤患者的SARS-CoV-2长期排毒:病例报告
Infect Dis (Lond). 2022 Jul;54(7):529-533. doi: 10.1080/23744235.2022.2055136. Epub 2022 Mar 29.
6
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
7
Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.基于检测的 COVID-19 免疫功能低下患者解除隔离:循环阈值与 SARS-CoV-2 病毒培养。
Int J Infect Dis. 2021 Jul;108:112-115. doi: 10.1016/j.ijid.2021.05.027. Epub 2021 May 15.
8
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
9
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
10
Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase.评估新冠肺炎无症状或轻症患者后期的病毒脱落及传染性。
J Clin Med. 2020 Sep 10;9(9):2924. doi: 10.3390/jcm9092924.

本文引用的文献

1
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
2
Postvaccine Anti-SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients.肾移植受者接种疫苗后抗SARS-CoV-2刺突蛋白抗体的产生情况
Kidney Int Rep. 2021 Jun;6(6):1699-1700. doi: 10.1016/j.ekir.2021.04.017. Epub 2021 Apr 23.
3
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond.
严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗:免疫机制及其他
Vaccines (Basel). 2021 Feb 12;9(2):147. doi: 10.3390/vaccines9020147.
4
Case Report: Prolonged Viral Shedding in Six COVID-19 Patients.病例报告:六名 COVID-19 患者的病毒持续排出。
Am J Trop Med Hyg. 2021 Feb 24;104(4):1472-1475. doi: 10.4269/ajtmh.20-0933.
5
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.免疫功能低下患者中 SARS-CoV-2 的病毒持续排出。
J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4.
6
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.病例研究:一名患有癌症的无症状免疫功能低下个体长期感染性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)脱落。
Cell. 2020 Dec 23;183(7):1901-1912.e9. doi: 10.1016/j.cell.2020.10.049. Epub 2020 Nov 4.
7
Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?阈值循环值能否正确反映 2019 年新型冠状病毒病(COVID-19)的严重程度?
J Infect Chemother. 2021 Jan;27(1):117-119. doi: 10.1016/j.jiac.2020.09.010. Epub 2020 Sep 9.
8
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.病例报告:一名 COVID-19 女性患者病毒脱落 60 天。
Am J Trop Med Hyg. 2020 Jun;102(6):1210-1213. doi: 10.4269/ajtmh.20-0275.
9
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.通过细胞培养测定病毒 RNA 载量作为管理工具,以将 SARS-CoV-2 患者从传染病病房中出院。
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061. doi: 10.1007/s10096-020-03913-9. Epub 2020 Apr 27.
10
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.